Insmed IncorporatedINSMNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-2.94%
↑ 54% above average
Average (39q)
-6.43%
Historical baseline
Range
High:45.95%
Low:-83.02%
CAGR
+1.0%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -2.94% |
| Q2 2025 | -19.72% |
| Q1 2025 | -7.58% |
| Q4 2024 | -3.94% |
| Q3 2024 | 34.54% |
| Q2 2024 | -83.02% |
| Q1 2024 | 17.19% |
| Q4 2023 | -15.32% |
| Q3 2023 | 37.64% |
| Q2 2023 | -52.14% |
| Q1 2023 | 3.31% |
| Q4 2022 | -11.01% |
| Q3 2022 | -36.25% |
| Q2 2022 | 0.00% |
| Q1 2022 | 15.79% |
| Q4 2021 | 1.04% |
| Q3 2021 | 10.28% |
| Q2 2021 | -20.22% |
| Q1 2021 | 11.00% |
| Q4 2020 | -58.73% |
| Q3 2020 | 1.56% |
| Q2 2020 | 13.51% |
| Q1 2020 | -25.42% |
| Q4 2019 | 13.24% |
| Q3 2019 | 16.05% |
| Q2 2019 | 15.62% |
| Q1 2019 | 19.33% |
| Q4 2018 | -4.39% |
| Q3 2018 | -14.00% |
| Q2 2018 | -12.36% |
| Q1 2018 | -4.71% |
| Q4 2017 | -23.19% |
| Q3 2017 | 4.17% |
| Q2 2017 | -20.00% |
| Q1 2017 | 45.95% |
| Q4 2016 | -81.97% |
| Q3 2016 | -3.39% |
| Q2 2016 | -9.26% |
| Q1 2016 | -5.88% |
| Q4 2015 | -2.00% |